Literature DB >> 11436183

High glucose stimulates hyaluronan production by renal interstitial fibroblasts through the protein kinase C and transforming growth factor-beta cascade.

M Takeda1, T Babazono, K Nitta, Y Iwamoto.   

Abstract

Deposition of hyaluronan has been implicated in the pathogenesis of diabetic glomerulosclerosis. We hypothesized the involvement of hyaluronan in diabetic tubulointerstitial fibrosis. We investigated high-glucose effect on hyaluronan production by rat renal interstitial fibroblasts (normal rat kidney [NRK] cells) and examined the role of hyaluronan in NRK cell proliferation. The involvement of protein kinase C (PKC) and transforming growth factor-beta (TGF-beta) in this response was also examined. After 24 hours of incubation in medium containing 25.6 mmol/L glucose, production of hyaluronan by NRK cells was significantly increased compared with medium containing 5.6 mmol/L glucose (P <.01). L-glucose and mannitol had no effect on hyaluronan production. High glucose enhanced basal in situ PKC activity (P <.01), and both an activator of PKC (phorbol 12-myristate 13-acetate; [PMA]) and TGF-beta 1 were able to increase hyaluronan production by NRK cells (P <.01). The effect of high glucose on hyaluronan production was diminished by coincubating cells with PKC inhibitors (staurosporine [Stp] or calphostin C [CpC]) or with an anti-TGF-beta neutralizing antibody. Stimulation of hyaluronan production by PMA was also normalized by anti TGFbeta neutralizing antibody, but the effect of TGF-beta1 was not affected by inhibition of PKC. Finally, incubating quiescent NRK cells with 50 or 100 ng/mL hyaluronan for 24 hours significantly increased NRK cell number (P <.01). In conclusion, high glucose stimulates hyaluronan production through the PKC/TGF-beta cascade. Increased hyaluronan promotes NRK cell proliferation. These results suggest that hyaluronan may play a role in the pathogenesis of interstitial fibrosis in diabetic kidney disease. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11436183     DOI: 10.1053/meta.2001.24207

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Metabolism of a Glycosaminoglycan during Metamorphosis in the Japanese Conger eel, Conger myriaster.

Authors:  Yutaka Kawakami; Hiromi Oku; Kazuharu Nomura; Shigeaki Gorie; Hiromi Ohta
Journal:  Res Lett Biochem       Date:  2009-08-06

2.  Cyclin D3 mediates synthesis of a hyaluronan matrix that is adhesive for monocytes in mesangial cells stimulated to divide in hyperglycemic medium.

Authors:  Juan Ren; Vincent C Hascall; Aimin Wang
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

3.  Hyaluronan induces the selective accumulation of matrix- and cell-associated proteoglycans by mesangial cells.

Authors:  Sabine Kastner; Gareth J Thomas; Robert H Jenkins; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2007-11-01       Impact factor: 4.307

4.  Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3.

Authors:  Kirsi Rilla; Sanna Oikari; Tiina A Jokela; Juha M T Hyttinen; Riikka Kärnä; Raija H Tammi; Markku I Tammi
Journal:  J Biol Chem       Date:  2013-01-09       Impact factor: 5.157

Review 5.  Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis.

Authors:  Susan Yung; Kwok Fan Cheung; Qing Zhang; Tak Mao Chan
Journal:  Clin Dev Immunol       Date:  2013-09-22

6.  Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan.

Authors:  Sara Stridh; Fredrik Palm; Tomoko Takahashi; Mayumi Ikegami-Kawai; Peter Hansell
Journal:  Ups J Med Sci       Date:  2015-07-14       Impact factor: 2.384

7.  Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4.

Authors:  Travis Lear; Alison C McKelvey; Shristi Rajbhandari; Sarah R Dunn; Tiffany A Coon; William Connelly; Joe Y Zhao; Daniel J Kass; Yingze Zhang; Yuan Liu; Bill B Chen
Journal:  J Exp Med       Date:  2016-05-09       Impact factor: 14.307

8.  Cardiac fibroblast activation and hyaluronan synthesis in response to hyperglycemia and diet-induced insulin resistance.

Authors:  Daniel J Gorski; Anne Petz; Christina Reichert; Sören Twarock; Maria Grandoch; Jens W Fischer
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

9.  The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Autoimmune Dis       Date:  2012-08-01

10.  A hyaluronan synthesis inhibitor delays the progression of diabetic kidney disease in a mouse experimental model.

Authors:  Guillermo Selman; Laisel Martinez; Andrea Lightle; Alejandra Aguilar; Daniel Woltmann; Yuxuan Xiao; Roberto I Vazquez-Padron; Loay H Salman
Journal:  Kidney360       Date:  2021-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.